Calendar VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Market Closed - Nasdaq 04:00:00 2024-02-28 pm EST 5-day change 1st Jan Change
2.33 USD -1.69% Intraday chart for VYNE Therapeutics Inc. +7.37% 0.00%

Chart calendar VYNE Therapeutics Inc.

de52c3eb328c2cf428662c675b4fa.3Lm21BhwnaIklX-i2nV6tNlkTNxn1BUt2y1NhsfAE0w.v47ZoXki-dVL_z3VoxZO_5MMO6USt3Zhk0F10oSwSni0lNPkfD7ck2_xJg~61c4b7834a24a28fbbafc3478b9e097d

Upcoming events on VYNE Therapeutics Inc.

2024-02-28 Q4 2023 Earnings Release (Projected)
2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-08 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)

Past events on VYNE Therapeutics Inc.

2023-12-13 10:00 am Annual General Meeting
2023-11-13 07:45 am Q3 2023 Earnings Release
2023-11-09 01:30 pm R&D Day
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-14 08:00 am Q2 2023 Earnings Release
2023-06-04 BIO International Convention
2023-05-11 04:01 pm Q1 2023 Earnings Release
2023-03-30 03:30 pm H.C. Wainwright Autoimmune & Inflammatory Disease Conference
2023-03-09 04:01 pm Q4 2022 Earnings Release
2023-03-07 02:10 pm Cowen Health Care Conference
2023-01-12 10:00 am Extraordinary Shareholders Meeting
2023-01-09 LifeSci Partners Corporate Access Conference
2023-01-09 JP Morgan Healthcare Conference
2022-12-08 10:00 am Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
2022-12-01 12:30 pm Piper Sandler Healthcare Conference
2022-11-10 04:01 pm Q3 2022 Earnings Release
2022-09-13 12:30 pm H.C. Wainwright Global Investment Conference
2022-08-12 08:00 am Interim 2022 Earnings Release
2022-08-10 10:00 am Annual General Meeting
2022-07-26 B&T Cell-Mediated Autoimmune Disease Drug Development Conference

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
3,60
3,76
-4.36%
0,44
2,34
-81.04%
21,0
21,7
-3.3%
14,8
17,3
-14.51%
0,48
0,37
30.09%

0,50

EBITDA
Million USD
Released
Forecast
Spread
-74,6
-74,2
-0.57%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

-29,7

EBIT
Million USD
Released
Forecast
Spread
-74,9
-72,5
-3.33%
-95,9
-99,9
3.98%
-253
-190
-32.84%
-68,0
-65,9
-3.17%
-34,3
-36,6
6.17%

-32,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-74,0
-72,3
-2.34%
-95,4
-99,3
3.97%
-256
-259
1.04%
-73,8
-72,2
-2.26%
-33,9
-30,3
-12.17%

-28,7

Net income
Million USD
Released
Forecast
Spread
-74,2
-73,0
-1.58%
-95,2
-99,3
4.15%
-256
-258
1.03%
-73,3
-72,2
-1.63%
-23,2
-23,8
2.27%

-28,7

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-142
-121
-17.32%
-25,6
-24,7
-3.4%
-7,28
-8,52
14.55%

-7,66

Announcement Date28/02/1912/03/2004/03/2117/03/2209/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
4,09
4,76
-14.18%
2,29
4,12
-44.37%
0,18
0,37
-51.45%
0,13
0,10
26%
0,17
0,05
234%
0,01
0,06
-90%
0,10
0,00
-
0,14
0,05
170%
0,11
0,15
-24%

0,15

EBITDA
Million USD
Released
Forecast
Spread

























-10,8


-7,30

EBIT
Million USD
Released
Forecast
Spread
-17,8
-16,1
-10.71%
-12,0
-13,4
10.12%
-8,69
-8,67
-0.28%
-8,29
-9,77
15.15%
-9,33
-10,3
8.95%
-7,98
-10,3
22.49%
-5,88
-8,45
30.47%
-10,3
-10,6
2.66%






Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-21,3
-18,1
-17.84%
-12,0
-13,5
10.65%
-8,69
-8,90
2.31%
-8,24
-10,3
20.05%
-9,26
-8,90
-3.99%
-7,75
-10,6
26.56%
-5,61
-8,40
33.19%
-10,0
-8,70
-15.38%
-6,07
-10,6
42.73%

-7,00

Net income
Million USD
Released
Forecast
Spread
-21,3
-18,1
-17.84%
-11,6
-13,5
13.98%
4,67
-8,90
152.47%
-8,48
-10,3
17.71%
-9,46
-8,90
-6.28%
-9,95
-10,6
5.73%
-5,62
-8,40
33.07%
-10,1
-8,70
-15.61%
-6,58
-10,6
37.89%

-7,00

EPS
USD
Released
Forecast
Spread
-7,38
-5,76
-28.12%
-3,96
-4,50
12%
1,44
-2,94
148.98%
-2,70
-3,24
16.67%
-2,88
-2,82
-2.13%
-3,33
-3,24
-2.78%
-1,74
-2,61
33.33%
-3,09
-2,58
-19.77%
-2,01
-0,76
-164.47%

-0,50

Announcement Date10/11/2117/03/2212/05/2212/08/2210/11/2209/03/2311/05/2314/08/2313/11/23-

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW